6Baron RM,Baron MJ,Perrella MA.Pathobiology of sepsis:are we still asking the same questions? Am J Respir Cell Mol Biol,2006,34(2):129-134.
7Bone RC.Towards all epidemiology and nature history of SIRS.JAMA,1992,268(24):3452-3455.
8Dellinger RP,Carlet JM,Masur H.Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.Crit Care Med,2004,32(3):858-873.
9Cavaillon JM,Adib-Conquy M,Cloez-Tayarani I,et al.Immunodepressjon in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon:a review.J Endotoxin Res,2001,7(2):85-93.
10Wahl SM,Wen J,Moutsopoulos N.TGF-beta:a mobile purveyor of immune privilege.Immunol Rev,2006,213 213-227.
8Brun-Buisson C. The epidemiology of the systemic inflammato- ry response. Int Care Med, 2000,26( 1 ):64-74.
9Bone RC,Balk RA,Ceira FB,et al. Definitions for sepsis and organ failure and guidelines for the use of innovation therapies in sepsis. Chest, 1992,101(6) : 1644-1655.
10Pagliassett IMJ,Prach PA,Koppenhafer TA,et al.Changes in insulin action,triglycerides,and lipid composition during sucrose feeding in rats[J].Am J Physiol,1996,271(5 Pt 2):1319-1326.